Tianjin Chase Sun Pharmaceutical Co. LTD was founded in 1996. Under the leadership of YAO Xiaoqing, the founder and the chairman of the company, Chase Sun has been, so far, developed to an enterprise group which combines R&D, production, marketing and capital together, across modern TCM, chemical synthetic drugs, biotech drugs, medical devices and other fields.
- [Cooperation]Electrospinning polyurethane nanofiber technology2012-12-28
Electrospinning polyurethane nanofiber technology is the patented technology developed by Israel Nicast – the guide and pioneer of global electrospinning nanofiber technology applications in the medical field
- [Cooperation]PTS (p - toluene sulfonamide injection) project2012-12-28
PTS is the first intratumoral injection chemotherapy drug, at home and abroad, of efficient, broad-spectrum, low toxicity, specifically recognized dyeing, confirmed by the U.S. FDA "Targeted special toxicity” test. This innovative drug can be classified as 1.1-class chemical new drug in China.
- [Exchange]Tianjin Association for Medical International Exchange2013-01-28
Tianjin Association for Medical International Exchange, founded on April 16, 2012, is a nonprofit community group, supervised by Tianjin Food and Drug Administration.
- [Exchange]The leadership of the Tianjin Science and Technology Co...2012-12-28
In March 2011, the leadership of the Tianjin Science and Technology Commission and the Food and Drug Administration, as well as the chairman of Chase Sun Pharmaceutical, Yao Xiaoqing, went to Israel for investigation and project negotiation
- [Exchange]Our company signed a contract with Israel; Party Chief of...2012-12-28
In 2010, Chase Sun Pharmaceutical, Joining with Israel Infinity Capital Management Co., Ltd. and Tianjin Binhai Angel venture investment company, set up a platform of innovative technology introduction, hatching and promotion towards pharmaceutical and medical devices...